Focus: Charles River Laboratories is a global Contract Research Organization (CRO) with ~25,000 employees providing preclinical, clinical, and laboratory services to pharmaceutical and biotech companies. The company operates at scale with $4.1B in FY 2025 revenue and maintains a stable market position in drug development outsourcing.
Profile data last refreshed 1h ago · AI intelligence enriched 2w ago
5 recent layoff filings (12 mo) — 355 affected
Source: state DOL filings via Big Local News
No open roles listed right now. Follow Charles River Laboratories to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Charles River Laboratories's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Help build intelligence for Charles River Laboratories
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 3 crawl cycles
Source: USCIS H-1B Employer Data Hub
Source: state DOL filings, aggregated via Big Local News
Sustained restructuring activity spanning 5+ months with recurring, overlapping reduction notices suggests organizational turbulence; job security for existing and new hires is materially elevated risk.